Serum Visfatin Level in Psoriasis Patients: A Case-Control Study
Open Access
- 4 June 2024
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in The Open Dermatology Journal
- Vol. 18 (1)
Abstract
Background: Adipokines play imperative roles in the pathogenesis of psoriasis. Among the adipokines, visfatin is attracting more attention in the clinical setting of dermatology. Objective: The study aims to evaluate the serum visfatin level in psoriasis patients compared to the non-psoriasis individuals. Material and Methods: This case-control study involved 40 psoriasis patients and 40 non-psoriasis individuals from January to October, 2023, at the Ho Chi Minh City (HCMC) Hospital of Dermato-Venereology. The diagnosis of psoriasis was based on clinical signs and symptoms. Visfatin level was spectrophotometrically measured using an Enzym-Linked Immunosorbent Assay (ELISA) kit. Afterward, data analysis was performed using SPSS version 25. Results: We recorded a significantly higher visfatin level in the psoriasis group than the controls (49.8 ± 26.04 versus 13.07 ±12.44, p-value <0.001). The cut-off threshold of visfatin level to differentiate psoriasis from non-psoriasis was 21.7 ng/ml with a sensitivity of 90% and a specificity of 85% (AUC = 0.929). We also found a positive correlation between visfatin level and Psoriasis Area and Severity Index (PASI) score (r = 0.704; p <0.001). Conclusion: Our study indicated the link between serum level of visfatin and psoriasis. Visfatin is a potential biomarker in diagnosing psoriasis and classifying the disease’s severity. In further cohort studies and clinical trials, the adipokine can be validated for its use in psoriasis.Keywords
This publication has 56 references indexed in Scilit:
- Burden of skin disease and associated socioeconomic status in Asia: A cross-sectional analysis from the Global Burden of Disease Study 1990-2017JAAD International, 2021
- Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseasesJournal of Cellular Physiology, 2021
- Cytokines in psoriasis2021
- Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin2017
- Changes in concentration of visfatin during four weeks of inpatient treatment of alcohol dependent malesAlcoholism and Drug Addiction, 2015
- Serum Visfatin, Fetuin‐A, and Pentraxin 3 Levels in Patients With Psoriasis and Their Relation to Disease SeverityJournal of Clinical Laboratory Analysis, 2015
- Increased serum visfatin levels in obesity and its association with anthropometric/biochemical parameters, physical inactivity and nutritione-SPEN Journal, 2013
- Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activityDiabetologia, 2009
- Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterolDiabetes Research and Clinical Practice, 2008
- The applicability of the Asian modified criteria of the metabolic syndrome in the Korean populationInternational Journal of Cardiology, 2006